✦ LIBER ✦

KRASMutation is Associated with Worse Prognosis in Stage III or High-risk Stage II Colon Cancer Patients Treated with Adjuvant FOLFOX

✍ Scribed by Lee, Dae-Won; Kim, Kyung Ju; Han, Sae-Won; Lee, Hyun Jung; Rhee, Ye Young; Bae, Jeong Mo; Cho, Nam-Yun; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Jeong, Seung-Yong; Park, Kyu Joo; Park, Jae-Gahb; Kang, Gyeong Hoon; Kim, Tae-You

Book ID: 125406168
Publisher: Springer
Year: 2014
Tongue: English
Weight: 351 KB
Volume: 22
Category: Article
ISSN: 1068-9265
DOI: 10.1245/s10434-014-3826-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

E-selectin gene S128R polymorphism is as

E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer

✍ Mohamed Hebbar; Antoine Adenis; Françoise Révillion; Alain Duhamel; Olivier Roma 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Nuclear Maspin expression is associated

Nuclear Maspin expression is associated with response to adjuvant 5-fluorouracil based chemotherapy in patients with stage III colon cancer

✍ Wolfgang Dietmaier; Marcus Bettstetter; Peter J. Wild; Matthias Woenckhaus; Petr 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 528 KB

## Abstract Maspin, a member of the Serpin protease inhibitor family, is overexpressed in poorly differentiated colorectal tumors and more frequently found in tumors with microsatellite instability. Immunohistochemical nuclear Maspin staining is predominantly seen in tumor cells at the invasion fro

Stage III and oestrogen receptor negativ

Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer

✍ Hohaus, S; Funk, L; Martin, S; Schlenk, R F; Abdallah, A; Hahn, U; Egerer, G; Go 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 135 KB

Prognostic Value of Mucinous Histology D

Prognostic Value of Mucinous Histology Depends on Microsatellite Instability Status in Patients with Stage III Colon Cancer Treated with Adjuvant FOLFOX Chemotherapy: A Retrospective Cohort Study

✍ Kim, Se Hyun; Shin, Sang Joon; Lee, Kang Young; Kim, Hyunki; Kim, Tae Il; Kang, 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 269 KB

Gene-expression signature of tumor recur

Gene-expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5′fluoruracil-based adjuvant chemotherapy

✍ María Dolores Giráldez; Juan José Lozano; Míriam Cuatrecasas; Virginia Alonso-Es 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 French ⚖ 245 KB

6010 A three-arm phase III randomized tr

6010 A three-arm phase III randomized trial of FOLFOX-4 vs. FOLFOX-4 plus bevacizumab vs. XELOX plus bevacizumab in the adjuvant treatment of patients with stage III or high-risk stage II colon cancer: results of the interim safety analysis of the AVANT trial

✍ Hoff, P.; Clarke, S.; Cunningham, D.; Van Cutsem, E.; Moore, M.; Schmoll, H.J.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB